RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 121 filers reported holding RA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,047,000 | +17.0% | 134,600 | -12.8% | 0.28% | +75.6% |
| Q1 2019 | $3,458,000 | +929.2% | 154,400 | +289.9% | 0.16% | +788.9% |
| Q4 2017 | $336,000 | -28.1% | 39,600 | +23.8% | 0.02% | -28.0% |
| Q3 2017 | $467,000 | -56.6% | 32,000 | -44.3% | 0.02% | -62.1% |
| Q2 2017 | $1,075,000 | +53.6% | 57,400 | +74.5% | 0.07% | +50.0% |
| Q1 2017 | $700,000 | – | 32,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |